Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial

by | Jan 1, 2025 | Publicaciones - B-01 | 0 comments

López-Miranda, E; Pérez-García, JM; Gión, M; Ribelles, N; Cortez-Castedo, P; Alonso-Romero, JL; García, MM; González-Santiago, S; Bermejo, B; Morales, S; Carañana, V; Garrigós, L; Fernández-Pinto, M; Garcia-Vicente, S; García-Sanz, A; Mena-Molina, A; Boix, O; Alcalá-López, D; Llombart-Cussac, A; Cortés, J – 2025 – 10.1186/s13058-025-02089-4